A novel molecule could spur new class of drugs for breast cancer

(Stevens Institute of Technology) Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class of molecules that use a never-before-known mechanism that may halt or destroy breast cancer tumors, particularly for patients with drug-resistant or dangerously metastatic stages of the disease.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news